Background : To date, several studies have validated the use of key biomarkers such as IL-18, CXCL9 and S100 proteins in diagnosis and monitor treatment response of systemic juvenile idiopathic arthritis (sJIA). Here, IL18 is linked to systemic-onset juvenile idiopathic arthritis.